Pfizer Limited
Pfizer Limited, a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in India and operates extensively across the Asia-Pacific region. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health challenges. The company is renowned for its diverse portfolio, which includes treatments in areas such as oncology, cardiology, immunology, and infectious diseases. Pfizer Limited's commitment to research and development has led to significant breakthroughs, making its products unique in efficacy and safety. With a strong market position, Pfizer Limited has achieved numerous accolades for its contributions to healthcare, including the rapid development of vaccines during public health emergencies. This dedication to improving patient outcomes solidifies its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Pfizer Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Limited's score of 9 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pfizer Limited's reported carbon emissions
In 2023, Pfizer Limited reported total carbon emissions of approximately 3,659,000 kg CO2e, comprising 63,000 kg CO2e from Scope 1 and 3,653,000 kg CO2e from Scope 2 emissions. This marks a slight increase in Scope 2 emissions compared to 2022, where total emissions were about 3,478,000 kg CO2e, with 149,000 kg CO2e from Scope 1 and 3,433,000 kg CO2e from Scope 2. Despite these figures, Pfizer Limited has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on its operational emissions, but further details on long-term climate commitments or strategies to reduce overall emissions are not available. As a major player in the pharmaceutical industry, Pfizer's emissions profile reflects the broader challenges faced by the sector in addressing climate change and reducing carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 149,000 | 00,000 |
| Scope 2 | 3,433,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pfizer Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
